SCHEMBL2494532

SCHEMBL2494532

OCCOC(c1ccc(O)cc1)(c1ccc(O)cc1)c1ccc(O)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 2/20 0.41
ESR1 P03372 8/20 0.40
ESR2 Q92731 8/20 0.40
CYP3A4 P08684 3/20 0.39
LMNA P02545 2/20 0.39
TYR P14679 2/20 0.39
HPGD P15428 2/20 0.39
HSD17B10 Q99714 2/20 0.39
AR P10275 1/20 0.39
TSHR P16473 1/20 0.39
SLC6A2 P23975 1/20 0.39
SLC6A4 P31645 1/20 0.39
HTR6 P50406 1/20 0.39
ESRRG P62508 1/20 0.39
SLC6A3 Q01959 1/20 0.39
CA2 P00918 2/20 0.38
SHBG P04278 1/20 0.38
APP P05067 1/20 0.35
ALDH1A1 P00352 2/20 0.35
KDM4E B2RXH2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2492369 0.88 KIF11 (0.38) KIF11ESR1ESR2CYP3A4LMNA
SCHEMBL2490812 0.81 KIF11 (0.39) KIF11CYP3A4TSHRNPC1MAPT
SCHEMBL2493499 0.81 SLC6A1 (0.43) KIF11CYP3A4ALDH1A1NPC1RAB9A
SCHEMBL2491921 0.80 KIF11 (0.63) KIF11TSHRALDH1A1ALOX15RECQL
SCHEMBL2491594 0.78 SLC6A11 (0.45) CYP3A4LMNAHSD17B10CA2ALDH1A1
SCHEMBL12199493 0.75 KIF11 (0.52) KIF11ALDH1A1MEN1RECQLKMT2A
SCHEMBL2490410 0.72 SLC6A11 (0.50) KIF11CYP3A4MEN1KMT2A
SCHEMBL992028 0.72 SLC6A11 (0.50) KIF11CYP3A4MEN1KMT2A
SCHEMBL9142722 0.71 KIF11 (0.52) KIF11ESR1ESR2CYP3A4LMNA
Bisphenol A SCHEMBL9185720 0.71 ESR1 (0.64) ESR1ESR2CYP3A4LMNATYR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3009123-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2016-04-20 EP disclosed
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2015-11-19 US disclosed
EP-2845587-A2 Melanin production inhibitor Pola Chemical Industries Inc. (JP) 2015-03-11 EP disclosed
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2014-12-11 US disclosed
US-8846012-B2 Melanin production inhibitor POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-30 US disclosed
EP-2380567-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2011-10-26 EP disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, TH KIF11 4556/4885ESR1 3775/4885ESR2 3511/4885
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR TYR, MC1R, F12 KIF11 4605/4885ESR1 3785/4885ESR2 3465/4885
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, MC1R KIF11 4611/4885ESR1 3626/4885ESR2 3449/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.